Vetter Announces Office Opening in Japan

Vetter have announced the opening of a new business entity in Tokyo, Japan. The announcement was made at a ceremony attended by executives of customer and partner companies with a presence in the Asian region, as well as Vetter and industry executives. Mr Hiroaki Suzuki in his role as Business Development Manager for Vetter Pharma International Japan KK, will lead Vetter’s business activities in Japan, reporting to Ms Chervee Ho based in Singapore in her role as Director Key Account Management Asia Pacific.

“Our presence in Japan will help to increase awareness of Vetter’s services in this growing healthcare market by presenting our expertise and market position onsite,” said Managing Director, Peter Soelkner. “Following the creation of our Asia Pacific hub in Singapore last year, the new office is a further development, establishing a dedicated presence in the most important single market of the region. This activity affords us the opportunity to strengthen personal contacts with national audiences.” 

“Vetter’s decision to expand their presence in the Asia Pacific region and to open their first office in Japan is a strong message of their commitment to service the needs of this important market,” said Dr Hitoshi Kuboniwa, Senior Vice President and General Manager of Pharmaceutical Technology Division at Chugai Pharmaceutical Co, Ltd. “As a trusted partner, we appreciate that step, wishing Vetter as a company in general, and Ms Ho and Mr Suzuki in particular, a promising start for their onsite activities in Japan.”

The new office is located in district Shinagawa, on the 28th floor of a business tower directly across from Shinagawa station.  The office offers ease of accessibility for many JR Rail lines with proximity to international Haneda and Narita airport through direct train connections.